Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

MA Katzman, P Bleau, P Blier, P Chokka, K Kjernisted… - BMC psychiatry, 2014 - Springer
Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

The pharmacologic treatment of anxiety disorders: a review of progress

LN Ravindran, MB Stein - The Journal of clinical psychiatry, 2010 - psychiatrist.com
Anxiety disorders, as a group, are among the most common mental health conditions and
frequently cause significant functional impairment. Both psychotherapeutic and …

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic …

B Bandelow, J Zohar, E Hollander… - The World Journal of …, 2008 - Taylor & Francis
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

A meta-analysis of the efficacy of psycho-and pharmacotherapy in panic disorder with and without agoraphobia

K Mitte - Journal of affective disorders, 2005 - Elsevier
The efficacy of (cognitive) behavioural ((C) BT) and pharmacological therapy was
investigated using meta-analytic techniques. After a comprehensive review of the literature …

The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions

BF Grant, DS Hasin, FS Stinson… - Journal of Clinical …, 2006 - psychiatrist.com
Objective: To present nationally representative data on the prevalence, correlates, and
comorbidity of DSM-IV panic disorder (PAN), including the differentiation between panic with …

Pharmacotherapy for anxiety disorders: from first-line options to treatment resistance

AJ Melaragno - Focus, 2021 - psychiatryonline.org
In this review, the author examines the evidence for psychopharmacologic treatments
among adults for generalized anxiety disorder, panic disorder, and social anxiety disorder …

Benzodiazepines versus placebo for panic disorder in adults

J Breilmann, F Girlanda, G Guaiana… - Cochrane database …, 2019 - cochranelibrary.com
Background Panic disorder is characterised by recurrent unexpected panic attacks
consisting of a wave of intense fear that reaches a peak within a few minutes. Panic disorder …

Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety

JC Ballenger, JRT Davidson, Y Lecrubier… - Journal of Clinical …, 1998 - psychiatrist.com
Objective: To provide primary care clinicians with a better understanding of management
issues in panic disorder and guide clinical practice with recommendations for appropriate …

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic …

B Bandelow, J Zohar, E Hollander… - The World Journal of …, 2002 - Taylor & Francis
In this report, recommendations for the pharmacological treatment of anxiety and obsessive-
compulsive disorders are presented, based on available randomized, placebo-or …

[Књига][B] Anxiety Disorders in Adults A Clinical Guide

V Starcevic - 2009 - books.google.com
Using the practical yet comprehensive approach found in the first edition, the author
considers each anxiety disorder's clinical complexity while simultaneously using an …